149 related articles for article (PubMed ID: 22661058)
1. PET/CT in lung cancer: Influence of contrast medium on quantitative and clinical assessment.
Behrendt FF; Temur Y; Verburg FA; Palmowski M; Krohn T; Pietsch H; Kuhl CK; Mottaghy FM
Eur Radiol; 2012 Nov; 22(11):2458-64. PubMed ID: 22661058
[TBL] [Abstract][Full Text] [Related]
2. The influence of different contrast medium concentrations and injection protocols on quantitative and clinical assessment of FDG-PET/CT in lung cancer.
Verburg FA; Kuhl CK; Pietsch H; Palmowski M; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Oct; 82(10):e617-22. PubMed ID: 23880426
[TBL] [Abstract][Full Text] [Related]
3. Multiphase CT scanning and different intravenous contrast media concentrations in combined F-18-FDG PET/CT: Effect on quantitative and clinical assessment.
Rebière M; Verburg FA; Palmowski M; Krohn T; Pietsch H; Kuhl CK; Mottaghy FM; Behrendt FF
Eur J Radiol; 2012 Aug; 81(8):e862-9. PubMed ID: 22591760
[TBL] [Abstract][Full Text] [Related]
4. No clinically relevant differences between positron emission tomography (PET) reconstructions based on low-dose or contrast-enhanced CT in combined integrated multiphase (18) F-Fluorethylcholine PET/CT for prostate cancer.
Behrendt FF; Lensing C; Keil S; Mottaghy FM; Verburg FA
J Med Imaging Radiat Oncol; 2016 Aug; 60(4):498-505. PubMed ID: 27297449
[TBL] [Abstract][Full Text] [Related]
5. Body surface area adapted iopromide 300 mg/ml versus 370 mg/ml contrast medium injection protocol: influence on quantitative and clinical assessment in combined PET/CT.
Verburg FA; Apitzsch J; Lensing C; Kuhl CK; Pietsch H; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Dec; 82(12):2348-52. PubMed ID: 24113432
[TBL] [Abstract][Full Text] [Related]
6. Contrast medium injection protocol adjusted for body surface area in combined PET/CT.
Behrendt FF; Rebière M; Goedicke A; Pietsch H; Palmowski K; Kuhl CK; Mottaghy FM; Verburg FA
Eur Radiol; 2013 Jul; 23(7):1970-7. PubMed ID: 23423636
[TBL] [Abstract][Full Text] [Related]
7. Multiphase contrast-enhanced CT with highly concentrated contrast agent can be used for PET attenuation correction in integrated PET/CT imaging.
Aschoff P; Plathow C; Beyer T; Lichy MP; Erb G; Öksüz MÖ; Claussen CD; Pfannenberg C
Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):316-25. PubMed ID: 22124778
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of perfusion CT technique integrated into conventional 18FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study.
Ippolito D; Capraro C; Guerra L; De Ponti E; Messa C; Sironi S
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):156-65. PubMed ID: 23143661
[TBL] [Abstract][Full Text] [Related]
9. Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study.
Liu J; Li C; Hu M; Lu J; Shi X; Xing L; Sun X; Fu Z; Yu J; Meng X
Medicine (Baltimore); 2015 May; 94(17):e678. PubMed ID: 25929896
[TBL] [Abstract][Full Text] [Related]
10. Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancer.
Pfannenberg AC; Aschoff P; Brechtel K; Müller M; Bares R; Paulsen F; Scheiderbauer J; Friedel G; Claussen CD; Eschmann SM
Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):36-44. PubMed ID: 16896664
[TBL] [Abstract][Full Text] [Related]
11. Nonionic intravenous contrast agent does not cause clinically significant artifacts to 18F-FDG PET/CT in patients with lung cancer.
An YS; Sheen SS; Oh YJ; Hwang SC; Yoon JK
Ann Nucl Med; 2007 Dec; 21(10):585-92. PubMed ID: 18092135
[TBL] [Abstract][Full Text] [Related]
12. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of early and delayed FDG PET-CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients.
Schillaci O; Travascio L; Bolacchi F; Calabria F; Bruni C; Cicciò C; Guazzaroni M; Orlacchio A; Simonetti G
Radiol Med; 2009 Sep; 114(6):890-906. PubMed ID: 19579015
[TBL] [Abstract][Full Text] [Related]
14. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients.
Berthelsen AK; Holm S; Loft A; Klausen TL; Andersen F; Højgaard L
Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1167-75. PubMed ID: 15909196
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy.
Hwang SH; Yoo MR; Park CH; Jeon TJ; Kim SJ; Kim TH
Eur Radiol; 2013 Jun; 23(6):1573-81. PubMed ID: 23300040
[TBL] [Abstract][Full Text] [Related]
16. Does chemotherapy influence the quantification of SUV when contrast-enhanced CT is used in PET/CT in lymphoma?
Vera P; Ouvrier MJ; Hapdey S; Thillays M; Pesquet AS; Diologent B; Callonec F; Hitzel A; Edet-Sanson A; Ménard JF; Jardin F; Tilly H
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):1943-52. PubMed ID: 17694309
[TBL] [Abstract][Full Text] [Related]
17. Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging.
Brechtel K; Klein M; Vogel M; Mueller M; Aschoff P; Beyer T; Eschmann SM; Bares R; Claussen CD; Pfannenberg AC
J Nucl Med; 2006 Mar; 47(3):470-6. PubMed ID: 16513616
[TBL] [Abstract][Full Text] [Related]
18. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
[TBL] [Abstract][Full Text] [Related]
19. Improving the detection of small lesions using a state-of-the-art time-of-flight PET/CT system and small-voxel reconstructions.
Koopman D; van Dalen JA; Lagerweij MC; Arkies H; de Boer J; Oostdijk AH; Slump CH; Jager PL
J Nucl Med Technol; 2015 Mar; 43(1):21-7. PubMed ID: 25613334
[TBL] [Abstract][Full Text] [Related]
20. Detection of pancreatic neuroendocrine tumors (PNET) using semi-quantitative [68Ga]DOTATOC PET in combination with multiphase contrast-enhanced CT.
Froeling V; Röttgen R; Collettini F; Rothe J; Hamm B; Brenner W; Schreiter N
Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):310-8. PubMed ID: 25265251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
